Open-label, Randomized, Single-Dose, 2 Way Crossover Bioequivalence Study Comparing A New Alprazolam Sublingual Tablet Formulation To A Reference Alprazolam Immediate Release Tablet.
Phase of Trial: Phase I
Latest Information Update: 24 May 2011
At a glance
- Drugs Alprazolam; Alprazolam
- Indications Anxiety disorders
- Focus Pharmacokinetics
- 24 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2011 Planned end date changed from 1 Apr 2011 to 1 May 2011 as reported by ClinicalTrials.gov.
- 26 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.